Claustrophobia affects minority of MR scans
A study of more than 4800 hospital patients has established that claustrophobia remains an impediment for MRI practice and a difficult experience for about 2% of patients undergoing MR procedures.
A study of more than 4800 hospital patients has established that claustrophobia remains an impediment for MRI practice and a difficult experience for about 2% of patients undergoing MR procedures.
By reviewing imaging records, Dr. Iris Eshed and colleagues at Charite Medical Center in Berlin learned that 95 of 4821 patients complained of claustrophobia during routine clinical MR imaging on 1.5T scanners at the hospital in 2004. Among those cases, 59 were severe enough to prematurely halt imaging. The results were reported in the July issue of the Journal of Magnetic Resonance Imaging. Eshed's results match previous findings from other large cohort studies of MR-related claustrophobia.
Eshed recommended partial sedation and prone positioning when possible to control the number of prematurely terminated studies because of claustrophobia.
FDA Clears Magnetic Resonance Spectroscopy Platform for Non-Invasive Assessment of Brain Chemistry
November 29th 2023BrainSpec Core reportedly offers enhanced sensitivity for low-grade gliomas and may facilitate the diagnosis of conditions including Alzheimer’s disease, multiple sclerosis, and epilepsy.
Study Says Contrast-Enhanced Mammography Offers Comparable Breast Cancer Detection to MRI
November 15th 2023In findings from an enriched cohort of asymptomatic patients with screening-detected abnormalities, researchers found that contrast-enhanced mammography (CEM) was superior to conventional mammography and offered equivalent detection of breast cancer in comparison to breast MRI and abbreviated breast MRI.
Adjunctive Brain Volume Quantification Tool for MRI Gets FDA Clearance
November 14th 2023Providing automated brain volume calculations based on MRI images, NeuroShield’s artificial intelligence (AI)-powered technology may help facilitate treatment for neurodegenerative conditions ranging from Alzheimer’s disease to epilepsy.
